Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer: a Cross-sectional, Observational, and Analytical Study

NCT05300412 is registered in ClinicalTrials.gov with University Clinical Centre of Kosova as lead sponsor.

NCT NCT05300412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer: a Cross-sectional, Observational, and Analytical Study
Lead sponsor
University Clinical Centre of Kosova
Phase
Observational
Overall status
Completed
Start date
June 5, 2018
Completion date
December 20, 2019
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer invasive